Prof Sarah-Jane Dawson
Professorial Fellow
Centre for Cancer Research
181 Scholarly works
35 Projects
HIGHLIGHTS
2026
Research grants (ARC, NHMRC, MRFF)
Super-Next: Complete Genome Profiling for Cancer of Unknown Primary
2022
Journal article
Non-genetic determinants of malignant clonal fitness at single-cell resolution
DOI: 10.1038/s41586-021-04206-72022
Conference Proceedings
SUMOYLATION OF DNMT1 REGULATES RESPONSE TO CATALYTIC INHIBITION OF DNMT1 IN ACUTE MYELOID LEUKAEMIA
DOI: 10.1016/j.exphem.2022.07.1782020
Research grants (ARC, NHMRC, MRFF)
Super-Next: Complete Genome Profiling for Cancer of Unknown Primary
2019
Journal article
A phase Ib dose-escalation and expansion study of the BCL2 inhibitor venetoclax combined with tamoxifen in ER and BCL2– positive metastatic breast cancer
DOI: 10.1158/2159-8290.CD-18-11512019
Journal article
Dynamic molecular monitoring reveals that SWI–SNF mutations mediate resistance to ibrutinib plus venetoclax in mantle cell lymphoma
DOI: 10.1038/s41591-018-0243-z2018
Research Grant
Capture: Circulating Tumour Dna Assessment of Pik3ca to Guide Treatment Response
RECENT SCHOLARLY WORKS
2026
Journal article
Does the use of National Early Warning Scores (NEWS or NEWS2) in healthcare settings improve patient outcomes: a systematic review
DOI: 10.1186/s13643-026-03088-y2026
Journal article
Measuring and evaluating participant understanding of consent processes in clinical trials: a systematic review
DOI: 10.1186/s13063-026-09582-x2026
Journal article
Involving community members in designing behavioural weight management programmes: a scoping review
DOI: 10.1186/s12889-026-26210-02026
Journal article
Structured tools for assessing quality and risk of bias in Mendelian randomization studies: an updated systematic review
DOI: 10.1093/ije/dyag0522026
Journal article
Effectiveness of interventions to increase vaccine uptake: component network meta-analysis
DOI: 10.1136/bmj-2025-0875782026
Journal article
Interventions to increase vaccine uptake among socially excluded groups: A systematic review
DOI: 10.1016/j.vaccine.2026.1283142026
Journal article
Abstract PS1-10-07: Progression free survival and exploratory endpoints from PALVEN: a phase 1b study of palbociclib, letrozole and venetoclax in ER and BCL2-positive metastatic breast cancer
DOI: 10.1158/1557-3265.sabcs25-ps1-10-072026
Journal article
Abstract PD7-10: Neo-n (neon): three-year event-free survival and ultrasensitive ctdna dynamics in early triple-negative breast cancer (tnbc) treated with neoadjuvant carboplatin/paclitaxel and nivolumab
DOI: 10.1158/1557-3265.sabcs25-pd7-10